Customer in the us reported to biomérieux discrepant results and qcv failure in association with the vidas® analyzer (reference (b)(4)).An investigation was performed.Note: observing a qcv failure is not abnormal as the qcv is a functional control meant to detect residual risks, that are rare and sudden.These risks are already present and accepted into the vidas system risk analysis.As requested by biomérieux, the customer performed a retrospective analysis for tests which were performed on the slot 1 of the section d of the instrument.This retrospective analysis included re-running all tests which were run in slot d1 from 01mar2017 (date of the last conform qcv) to 03apr2017 (date of the qcv failure).According to the customer, the retrospective analysis showed that six (6) patient samples were affected : 2 mpg results were reported as negative instead of positive; 4 vzg results were reported as negative instead of positive.As stated by the customer, all other tests had the same result.For the six (6) false results, the customer stated that reports were corrected and that the doctors were notified.The customer confirmed that there was no consequence for the patients, no patient was harmed or treated incorrectly, and no patient was a pregnant woman, child, or immune-compromised.The investigation by the field service engineer (fse) at the customer site, identified the root cause of the qcv failure as a clog in the section d slot 1.This clog was confirmed by a result value not conforming in section d slot 1 when using the pump tester.The fse replaced the pump seals and cleaned the section d with the pump cleaner.Then the result value of the pump tester in the section d slot 1 was conforming, as the instrument was repaired.The fse performed a leak test and a qcv test and qualified the instrument.
|